Hara Y, Moro K, Ichikawa H, et al. Clinical Utility of Targeted Next-Generation Sequencing for Determining Human Epidermal Growth Factor Receptor 2 Status and Optimizing Targeted Therapy in Breast Cancer. World J Oncol. 2025;16(4):347-356. doi:10.14740/wjon2583